Clinical neuropharmacology

Label

• Clinical neuropharmacology (literal)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#rivistaDi

• IFNbeta-1a treatment and reestablishment of TH1 regulation in MS patients: dose effects. (Articolo in rivista) (Prodotto della ricerca)
• Quetiapine and clozapine in parkinsonian patients with dopaminergic psychosis. (Articolo in rivista) (Prodotto della ricerca)
• Increased power spectrum and synchronization of EEg gamma frequencies after vagus nerve stimulation in adults with refractory partila epilepsy (Articolo in rivista) (Prodotto della ricerca)
• Body weight influences pharmacokinetics of levodopa in Parkinson's disease (Articolo in rivista) (Prodotto della ricerca)
• Motor response to apomorphine in patients with Parkinson's disease with long-duration response to levodopa (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
• The Long-term Effect of Tetrabenazine in the Management of Huntington Disease. (Articolo in rivista) (Prodotto della ricerca)
• Single Photon Emission Computed Tomography Striatal Asymmetry Index May Predict Dopaminergic Responsiveness in Parkinson Disease (Articolo in rivista) (Prodotto della ricerca)
• Hormonal replacement therapy in women with Parkinson disease and levodopa-induced dyskinesia: a crossover trial. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
• Regional Cerebral Glucose Metabolism After Pridopidine (ACR16) Treatment in Patients With Huntington Disease (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)

Alternative label

• Clin. neuropharmacol. (literal)
• Clinical neuropharmacology. (literal)

Language

• eng (literal)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#issn

• 0362-5664 (literal)

Preferred label

• Clinical neuropharmacology (literal)

Publisher

• Raven Press, New York, USA (literal)

Incoming links:

Rivista

• IFNbeta-1a treatment and reestablishment of TH1 regulation in MS patients: dose effects. (Articolo in rivista) (Prodotto della ricerca)
• Regional Cerebral Glucose Metabolism After Pridopidine (ACR16) Treatment in Patients With Huntington Disease (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
• Increased power spectrum and synchronization of EEg gamma frequencies after vagus nerve stimulation in adults with refractory partila epilepsy (Articolo in rivista) (Prodotto della ricerca)
• Body weight influences pharmacokinetics of levodopa in Parkinson's disease (Articolo in rivista) (Prodotto della ricerca)
• Motor response to apomorphine in patients with Parkinson's disease with long-duration response to levodopa (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
• Hormonal replacement therapy in women with Parkinson disease and levodopa-induced dyskinesia: a crossover trial. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
• Quetiapine and clozapine in parkinsonian patients with dopaminergic psychosis. (Articolo in rivista) (Prodotto della ricerca)
• The Long-term Effect of Tetrabenazine in the Management of Huntington Disease. (Articolo in rivista) (Prodotto della ricerca)
• Single Photon Emission Computed Tomography Striatal Asymmetry Index May Predict Dopaminergic Responsiveness in Parkinson Disease (Articolo in rivista) (Prodotto della ricerca)